Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-6 in serum as diagnostic markers in pulmonary sarcoidosis

T. Kadowaki, H. Hamada, N. Hamaguchi, K. Sakai, R. Ito, J. Higaki (Toon, Ehime, Japan)

Source: Annual Congress 2007 - Sarcoidosis: various aspects
Session: Sarcoidosis: various aspects
Session type: Thematic Poster Session
Number: 796
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Kadowaki, H. Hamada, N. Hamaguchi, K. Sakai, R. Ito, J. Higaki (Toon, Ehime, Japan). Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-6 in serum as diagnostic markers in pulmonary sarcoidosis. Eur Respir J 2007; 30: Suppl. 51, 796

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
YKL-40, soluble IL-2 receptor, ADA and neopterin: comparison of markers of sarcoidosis activity
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009

Biomarkers of Sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme and KL-6
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019

Clinical value of soluble interleukine-2 receptor (sIL-2R) serum level examination in the pulmonary sarcoidosis (PS)
Source: Eur Respir J 2003; 22: Suppl. 45, 226s
Year: 2003

Comparative study of CC16, KL-6 and SP-D as serum markers in sarcoid patients
Source: Eur Respir J 2002; 20: Suppl. 38, 173s
Year: 2002

Serum TNFα, CD14 and CRP levels in COPD patients with different alpha-1 antitrypsin phenotypes
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008


Circulating d-Dimer lysozyme and angiotensin-converting enzyme in active sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 196s
Year: 2001

Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


The relationship between serum soluble interleukin-2 receptor levels and disease severity in sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 355s
Year: 2006

Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008


Correlation of HRCT proven inflammatory changes with serum levels of ACE, sIL-2r and calciuria in pulmonary sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 226s
Year: 2003

Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006

Serum KL-6, SP-D and MMP-2 as diagnostic biomarkers in asbestosis and silicosis
Source: International Congress 2017 – Silicosis has not gone away
Year: 2017




The relation of serum interleukin-6 and C-reactive protein to clinical parameters in pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 35s
Year: 2004

Human napsin a is a useful serum marker of interstitial lung disease, compared to KL-6, and surfactant protein-D
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Correlation between the serum angiotensin converting enzyme (SACE) level and the bronchoalveolar lavage pattern in newly diagnosed pulmonary sarcoidosis stage 1
Source: Eur Respir J 2002; 20: Suppl. 38, 469s
Year: 2002

Value of serum angiotensin converting enzyme (SACE) level in the assessment of lung parenchyma impairment in newly diagnosed sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003

Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

An association between sarcoidosis and serum immunoglobulin levels
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Evaluation of serum concentration of soluble interleukin-2 receptors (sIL-2R) in different respiratory tract diseases
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009

Serum angiotensin converting enzyme (ACE) as additional clinical markers of activity of pulmonary and extra-pulmonary locations of sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011